Table: Solasia Pharma -2025 parent results
Feb 13 (Reuters)-
Solasia Pharma K. K.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2025 Dec 31, 2024 Dec 31, 2026 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 429 mln 316 mln
(+35.4 pct) (-48.7 pct)
Operating loss 871 mln loss 840 mln
Recurring loss 897 mln loss 869 mln
Net loss 897 mln loss 868 mln
EPS loss 3.78 yen loss 4.37 yen
EPS Diluted loss 3.78 yen loss 4.37 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Solasia Pharma K. K..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4597.T